Ultragenyx Pharmaceutical stockRARE
Ultragenyx Pharmaceutical trades at $15.57, 61.0% below its 52-week high (Dec 8, 2025). The price is below its 50- and 200-day averages, a downtrend. −32.3% year to date, −51.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 18, 2027.
Ratings, candles, signals and the screener for RARE — after you log in
Open the terminalFrequently asked questions about Ultragenyx Pharmaceutical
What is the Ultragenyx Pharmaceutical stock price?
At the close on Nov 5, 2026: $15.57 (−9.27% on the day). 52-week high: $39.89 on Dec 8, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Ultragenyx Pharmaceutical report earnings?
The next quarterly report is on Feb 18, 2027. Last quarter, earnings per share changed +36% year over year, revenue +8%.
Does Ultragenyx Pharmaceutical pay dividends?
No, Ultragenyx Pharmaceutical does not pay dividends.
Where does Ultragenyx Pharmaceutical trade and how to buy it?
Ticker RARE, exchange Nasdaq, listed since 2014. You can buy it through a broker with access to US exchanges.
Should I buy Ultragenyx Pharmaceutical now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for RARE are in the terminal after you log in.